Skip to content
  • Pharma SOP’s
  • Schedule M
  • Pharma tips
  • Pharma Stability Studies

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Tag: documentation control

Never Rely on Memory to Record GMP Observations or Results

Posted on May 14, 2025 By digi

Never Rely on Memory to Record GMP Observations or Results Document Observations Immediately—Don’t Rely on Memory Remember: All GMP observations and results must be recorded contemporaneously—memory is not a valid data source. Why This Matters in GMP In GMP environments, every observation, measurement, or deviation must be documented at the time it occurs. Delayed entries…

Read More “Never Rely on Memory to Record GMP Observations or Results” »

GMP Tips

Avoid Manual Data Corrections Without Proper Justification

Posted on May 9, 2025 By digi

Avoid Manual Data Corrections Without Proper Justification Never Perform Manual Data Corrections Without Justification Remember: All corrections to GMP data must be explained, signed, dated, and reviewed — never make undocumented changes. Why This Matters in GMP In regulated environments, every data entry is subject to traceability and verification. Manual corrections without justification raise serious…

Read More “Avoid Manual Data Corrections Without Proper Justification” »

GMP Tips

Never Replace Approved SOPs with Verbal Instructions in GMP

Posted on May 8, 2025 By digi

Never Replace Approved SOPs with Verbal Instructions in GMP Follow Approved SOPs—Never Use Verbal Instructions in GMP Remember: Verbal instructions must not replace approved SOPs in any GMP-regulated activity. Why This Matters in GMP Standard Operating Procedures (SOPs) are the backbone of GMP compliance. They ensure consistency, reproducibility, and control across all operations. When personnel…

Read More “Never Replace Approved SOPs with Verbal Instructions in GMP” »

GMP Tips

Never Approve Batches Without Complete Analytical Test Reports

Posted on May 5, 2025 By digi

Never Approve Batches Without Complete Analytical Test Reports Do Not Approve Any Batch Without Full Analytical Reports Remember: Ensure all required analytical test reports are reviewed and approved before batch release. Why This Matters in GMP Approving a batch without all relevant analytical reports compromises product quality assurance and puts patients at risk. Every batch…

Read More “Never Approve Batches Without Complete Analytical Test Reports” »

GMP Tips

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • GMP Blog
Widget Image
  • Do Not Stockpile Rejected Units in Pharmaceutical Dispensing Areas

    Do Not Stockpile Rejected Units… Read more

documentation control

  • Never Rely on Memory to Record GMP Observations or Results
  • Avoid Manual Data Corrections Without Proper Justification
  • Never Replace Approved SOPs with Verbal Instructions in GMP
  • Never Approve Batches Without Complete Analytical Test Reports

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme